Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

51.9K
Overview
51.9K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.2K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.2K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

237
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
237
Types of RNA01:23

Types of RNA

73.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.2K
Types of Hormones02:13

Types of Hormones

84.6K
Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
84.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Incidence of Recurrent Respiratory Papillomatosis (RRP) in Denmark and Sweden During 2000-2023: Two Nationwide Cohort Studies in Children and Young Adults.

Open forum infectious diseases·2026
Same author

Racial Disparities and Personal Responsibility Incentives in Medicaid.

Health services research·2026
Same author

Incidence of human papillomavirus infections in women aged 27 years and older in the US: A federated data network study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Dengue Incidence, Seroprevalence, and Expansion Factors from Active Surveillance, Brazil, 2016-2021.

Emerging infectious diseases·2026
Same author

High Risk of Incident-Persistent Human Papillomavirus Infection With 9-Valent Vaccine Types in Young Men With an HPV Infection.

Open forum infectious diseases·2026
Same author

Etiologic heterogeneity across oral cavity cancers.

Cancer·2026

相关实验视频

Updated: Feb 16, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.3K

在HPV疫苗接种后的HPV类型替代

Elizabeth M Anderson1, Alfred J Saah1, Joseph E Tota2

  • 1Merck & Co., Inc., Rahway, NJ, USA.

Current topics in microbiology and immunology
|February 15, 2026
PubMed
概括

人类乳头瘤病毒 (HPV) 疫苗接种可以预防HPV引起的癌症. 非疫苗HPV类型的潜在增加可能是由于临床或病毒揭露,而不是类型更换.

科学领域:

  • 在瘤学瘤学.
  • 病毒学 病毒学
  • 公共卫生 公共卫生

背景情况:

  • 人类乳头瘤病毒 (HPV) 疫苗接种在预防HPV引起的癌症方面非常有效.
  • 人们担心,疫苗接种后非疫苗型HPV类型的癌前发病率可能会增加.
  • 这种现象可能会挑战HPV疫苗接种计划的感知影响.

研究的目的:

  • 探索疫苗接种后时期观察到非疫苗型HPV类型的增加的潜在解释.
  • 为了区分HPV类型替代,临床揭露和病毒揭露作为原因.
  • 阐明这些过程的潜在机制.

主要方法:

  • 审查有关HPV流行病学和疫苗影响的现有文献.
  • 拟议机制的分析:HPV类型替代,临床揭露和病毒揭露.
  • 讨论病毒遗传稳定性和HPV共感染动态.

主要成果:

  • 由于病毒遗传稳定性和缺乏类型间竞争,HPV类型替代被认为不太可能.
  • 临床揭露是合理的,因为对于疫苗类型的干预减少可能使非疫苗类型的进展.
  • 病毒揭示,一个测试文物,提出了类型替换错误发现的可能性.
关键词:
临床揭露 临床揭露这种疫苗是HPV疫苗.人类乳头瘤病毒 人类乳头瘤病毒替代型号 替代型号 替代型号 替代型号疫苗的有效性 疫苗的有效性病毒的揭露 病毒的揭露

更多相关视频

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
10:16

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

8.4K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

相关实验视频

Last Updated: Feb 16, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.3K
Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
10:16

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

8.4K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

结论:

  • 观察到非疫苗HPV类型的增加很可能归因于临床或病毒揭露,而不是真正的类型替代.
  • 了解这些机制对于准确评估HPV疫苗有效性至关重要.
  • 需要进一步的研究来证实主导机制及其对宫癌预防策略的影响.